Financhill
Back

McKesson Vs. SpringWorks Therapeutics Industry Stock Comparison

Sell
42

MCK
McKesson

Last Price:
503.90
Seasonality Move:
3.02%
Sell
22

SWTX
SpringWorks Therapeutics

Last Price:
38.69
Seasonality Move:
12.83%
Sell
42
McKesson (MCK) is a Sell

Is McKesson a Buy, Sell or Hold?

  • The current McKesson [MCK] share price is $504.17. The Score for MCK is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • MCK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $38.70. The Score for SWTX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • SWTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MCK Stock Price Chart

What is McKesson's stock price today?

  • The McKesson share price today is $504.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCK is experiencing selling pressure, which indicates risk of future bearish movement.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $38.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.

MCK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.73 Sell
Relative Strength Index (14 RSI): 28.41 Sell
Chaikin Money Flow: -1708931 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (531.58 - 589.78) Sell
Bollinger Bands (100): (540.96 - 595.52) Sell

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.86 Buy
Relative Strength Index (14 RSI): 48.43 Sell
Chaikin Money Flow: -246559 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.31 - 41.03) Buy
Bollinger Bands (100): (36.62 - 43.22) Sell

MCK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 548.6 Sell
20-day SMA: 549.72 Sell
50-day SMA: 575.43 Sell
200-day SMA: 532.1 Sell
8-day EMA: 541.28 Sell
20-day EMA: 554.29 Sell
50-day EMA: 566.12 Sell
200-day EMA: 533.09 Sell

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.65 Sell
20-day SMA: 39.22 Sell
50-day SMA: 38.12 Buy
200-day SMA: 40.78 Sell
8-day EMA: 40.17 Sell
20-day EMA: 39.42 Sell
50-day EMA: 38.9 Sell
200-day EMA: 38.59 Buy

McKesson Earnings Growth & MCK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.31 per share, an increase next quarter of $0.26 per share, an increase this year of $1.74 per share, and an increase next year of $4.55 per share.

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, an increase next quarter of $0.57 per share, an increase this year of $1.06 per share, and an increase next year of $1.38 per share.

McKesson Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):